Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

FDA advisory committee recommends approval of capecitabine

March 23, 1998

Cellomics receives funding for novel anticancer agent screens

March 23, 1998

Introgen granted option for tumor suppressor gene

March 20, 1998

Approval recommended for Gemzar supplemental NDA

March 20, 1998

New antineoplastic glutamic acid derivatives synthesized at Princeton

March 20, 1998

Mechanism of chemopreventive activity of resveratrol identified

March 19, 1998

Anticancer drug discovery collaboration initiated by Tripos, MDS Panlabs and Cell Pathways

March 18, 1998

Verapamil analogues reverse MDR in cancer cells

March 18, 1998

Isis reports incident of data manipulation; clinical progress will not be affected

March 17, 1998

Third phase II trial begins of ONYX-015 in head and neck cancer

March 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...